Overview

This course is designed for healthcare professionals seeking a rigorous, evidence-based understanding of epilepsy and cannabis. It combines contemporary science, clinical reasoning and international regulatory perspective.

Learning objectives

1) Understand the scientific basis for the use of cannabis in epilepsy. 2) Interpret the current clinical evidence and its limitations. 3) Apply the evidence responsibly within your regulatory framework.

Why Take This Course?

Evidence-based knowledge — Understand what the current research actually shows about epilepsy and medicinal cannabis. Clinical relevance — Connect scientific evidence with real-world clinical decision-making. Understand the endocannabinoid system — Learn the biological mechanisms that make cannabinoids relevant to neurological conditions. Evaluate the evidence critically — Recognise the strengths, limitations, and gaps in current research. Improve patient conversations — Gain the knowledge to discuss medicinal cannabis with patients in a clear, informed, and responsible way.

Curriculum

3 Chapters · 8 Lessons

    1. (Included in full purchase)

      Welcome to your course

    2. (Included in full purchase)

      Welcome Prof Mike Barnes

    3. (Included in full purchase)

      Learning Outcomes

    4. (Included in full purchase)

      Your Video Settings

    1. (Included in full purchase)

      Epilepsy Part 1 - Profesor Mike Barnes

    2. (Included in full purchase)

      Epilepsy Part 2

    1. (Included in full purchase)

      Epilepsy and Cannabis Quiz

    2. (Included in full purchase)

      Certificate of Completion

Professor Mike Barnes

Consultant Neurologist & Medical Cannabis Pioneer MD FRCP · Honorary Professor of Neurological Rehabilitation · Chair, Medical Cannabis Clinicians Society Professor Michael P. Barnes MD FRCP is a neurologist and Honorary Professor of Neurological Rehabilitation with more than 20 years' experience in the field of medical cannabis. He contributed to the development of Sativex, the first licensed cannabis-based medicine, and in 2016 authored a report for the UK Parliament examining the efficacy and safety of cannabis as a medicine. In 2018, Professor Barnes helped secure the UK's first licence for the prescription of medical cannabis for a child with epilepsy, contributing to the developments that preceded the change in UK law later that year.  He subsequently established the Medical Cannabis Clinicians Society (MCCS), of which he remains Chair, and later helped establish the Cannabis Industry Council.